231 related articles for article (PubMed ID: 31659833)
21. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
[TBL] [Abstract][Full Text] [Related]
22. SDRIFE (baboon syndrome) induced by penicillin.
Handisurya A; Stingl G; Wöhrl S
Clin Exp Dermatol; 2009 Apr; 34(3):355-7. PubMed ID: 18699835
[TBL] [Abstract][Full Text] [Related]
23. Levofloxacin-induced symmetric drug-related intertriginous and flexural exanthema.
Tsai YW; Chung WH; Wang CW; Cheng CY
Contact Dermatitis; 2022 Jan; 86(1):64-66. PubMed ID: 34553784
[No Abstract] [Full Text] [Related]
24. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
[TBL] [Abstract][Full Text] [Related]
25. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
[No Abstract] [Full Text] [Related]
26.
Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
[TBL] [Abstract][Full Text] [Related]
27. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin.
Moreira C; Cruz MJ; Cunha AP; Azevedo F
An Bras Dermatol; 2017; 92(4):587-588. PubMed ID: 28954125
[No Abstract] [Full Text] [Related]
28. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) induced by omeprazole.
Kardaun SH; Tupker RA
Int J Dermatol; 2012 Sep; 51(9):1134-7. PubMed ID: 21470217
[No Abstract] [Full Text] [Related]
29. Maculopapular rash due to fluconazole.
Di Leo E; Nettis E; Priore MG; Ferrannini A; Vacca A
Clin Exp Dermatol; 2009 Apr; 34(3):404. PubMed ID: 18627382
[No Abstract] [Full Text] [Related]
30. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) with fever induced by oral cloxacillin: does fever confound the diagnosis?
Chong WS; Lim HL
J Dermatol; 2010 Sep; 37(9):830-2. PubMed ID: 20883371
[No Abstract] [Full Text] [Related]
31. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
[No Abstract] [Full Text] [Related]
32. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P
Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764
[TBL] [Abstract][Full Text] [Related]
33. Symmetrical drug-related intertriginous and flexural exanthema due to codeine.
Erfan G; Yanik ME; Kaya S; Tasolar K; Oznur M; Kulac M
Indian J Dermatol Venereol Leprol; 2015; 81(4):405-6. PubMed ID: 26087105
[No Abstract] [Full Text] [Related]
34. Acute generalized exanthematous pustulosis induced by itraconazole.
Park YM; Kim JW; Kim CW
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):794-6. PubMed ID: 9146550
[No Abstract] [Full Text] [Related]
35. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
Cohen PR
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
[TBL] [Abstract][Full Text] [Related]
36. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide.
Ferreira O; Mota A; Morais P; Cunha AP; Azevedo F
Cutan Ocul Toxicol; 2010 Dec; 29(4):293-5. PubMed ID: 20522001
[TBL] [Abstract][Full Text] [Related]
37. Epidermal Growth Factor Receptor Inhibitor-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
Lewis W; Forrestel A; Baumrin E
Cutis; 2023 Jan; 111(1):18-21. PubMed ID: 36947773
[TBL] [Abstract][Full Text] [Related]
38. Itraconazole-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): a rare occurrence.
Kalita BJ; Das S; Dutta B
Int J Dermatol; 2020 Nov; 59(11):e419-e421. PubMed ID: 32767394
[No Abstract] [Full Text] [Related]
39. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
[No Abstract] [Full Text] [Related]
40. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema.
Kim EY; Awh KC; Larocca CA
Acta Derm Venereol; 2023 Dec; 103():adv12197. PubMed ID: 38112207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
